HUN-REN SZEGEDI BIOLOGIAI KUTATOKOZPONT

Their core work

HUN-REN Biological Research Centre Szeged is Hungary's leading life sciences research institute, specializing in molecular biology, evolutionary genomics, and translational medicine. Their core work spans antimicrobial resistance evolution, fungal genetics, advanced microscopy, and algae-based biotechnology. They serve as a key node in Hungary's molecular medicine infrastructure through their role in establishing the Hungarian Centre of Excellence for Molecular Medicine (HCEMM) in partnership with EMBL. Their research bridges fundamental biology with medical and energy applications, from inflammatory bowel disease treatments to bio-photovoltaic devices.

What they specialise in

How they've shifted over time

In 2015–2018, BRC Szeged focused heavily on building institutional capacity in molecular medicine (HU-MOLMEDEX, HCEMM) and launched ambitious fundamental research in antimicrobial resistance evolution and epigenetics. From 2019 onward, their focus shifted toward applied biology: algae-based energy production, microbiome-gut health connections, advanced microscopy techniques, and evolutionary genomics of fungi. The transition suggests a centre moving from establishing its molecular medicine credentials toward diversifying into bio-energy, food-health intersections, and computational biology.

BRC Szeged is expanding from pure molecular biology toward interdisciplinary applications — particularly algae biotechnology for both energy and health — making them an increasingly versatile partner for bio-based innovation projects.

How they like to work

BRC Szeged operates as both a project leader and a valued consortium partner, coordinating 4 of their 12 projects (33%), including their two largest grants. Their 104 unique partners across 22 countries indicate a broad, well-connected European network rather than a narrow circle of repeat collaborators. This balance of leadership and partnership experience makes them flexible — capable of driving a work package or anchoring an entire project depending on the consortium's needs.

With 104 unique consortium partners spanning 22 countries, BRC Szeged has one of the broader collaborative networks for a Hungarian research centre. Their partnerships reach across Western and Central Europe, with particularly strong ties to EMBL and the broader molecular medicine community.

What sets them apart

BRC Szeged is one of very few Central European research centres that combines ERC-level fundamental research (two ERC grants as coordinator) with applied biotechnology in algae and microbiome health. Their EMBL partnership through HCEMM gives them direct access to one of Europe's top molecular biology networks — a connection rare outside Western Europe. For consortium builders, they offer strong scientific credibility, competitive costs compared to Western European partners, and proven ability to lead international projects.

Highlights from their portfolio

• resistance evolution
  Their largest project (EUR 1.85M ERC Starting Grant) on antimicrobial resistance evolution — a 7-year effort they coordinated, reflecting deep expertise in evolutionary microbiology.
• Multicellularity
  ERC Consolidator Grant (EUR 1.49M) investigating how fungi independently evolved multicellularity — a fundamental biology question requiring advanced bioinformatics and single-cell methods.
• HCEMM
  Established Hungary's Centre of Excellence for Molecular Medicine in partnership with EMBL — a strategic infrastructure project positioning Szeged as a regional hub for translational medicine.